CALABRESI, LAURA
CALABRESI, LAURA
Medicina Sperimentale e Clinica
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs
2021 Balliu M.; Calabresi L.; Bartalucci N.; Romagnoli S.; Maggi L.; Manfredini R.; Lulli M.; Guglielmelli P.; Vannucchi A.M.
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles
2017 Zini, Roberta; Guglielmelli, Paola; Pietra, Daniela; Rumi, Elisa; Rossi, Chiara; Rontauroli, Sebastiano; Genovese, Elena; Fanelli, Tiziana; Calabresi, Laura; Bianchi, Elisa; Salati, Simona; Cazzola, Mario; Tagliafico, Enrico; Vannucchi, Alessandro M.; Manfredini, Rossella
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants
2019 Salati S.; Genovese E.; Carretta C.; Zini R.; Bartalucci N.; Prudente Z.; Pennucci V.; Ruberti S.; Rossi C.; Rontauroli S.; Enzo E.; Calabresi L.; Balliu M.; Mannarelli C.; Bianchi E.; Guglielmelli P.; Tagliafico E.; Vannucchi A.M.; Manfredini R.
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value
2014 Vannucchi, A.M.; Rotunno, G.; Bartalucci, N.; Raugei, G.; Carrai, V.; Balliu, M.; Mannarelli, C.; Pacilli, A.; Calabresi, L.; Fjerza, R.; Pieri, L.; Bosi, A.; Manfredini, R.; Guglielmelli, P.
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.
2014 Vannucchi AM;Rotunno G;Bartalucci N;Raugei G;Carrai V;Balliu M;Mannarelli C;Pacilli A;Calabresi L;Fjerza R;Pieri L;Bosi A;Manfredini R;Guglielmelli P
Characterization of novel molecular targets and mechanisms in Philadelphia-negative Myeloproliferative Neoplasms
2018 CALABRESI LAURA
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms
2023 Calabresi, Laura; Carretta, Chiara; Romagnoli, Simone; Rotunno, Giada; Parenti, Sandra; Bertesi, Matteo; Bartalucci, Niccolò; Rontauroli, Sebastiano; Chiereghin, Chiara; Castellano, Sara; Gentili, Giulia; Maccari, Chiara; Vanderwert, Fiorenza; Mannelli, Francesco; Della Porta, Matteo; Manfredini, Rossella; Vannucchi, Alessandro Maria; Guglielmelli, Paola
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms
2023 Calabresi, Laura; Carretta, Chiara; Romagnoli, Simone; Rotunno, Giada; Parenti, Sandra; Bertesi, Matteo; Bartalucci, Niccolò; Rontauroli, Sebastiano; Chiereghin, Chiara; Castellano, Sara; Gentili, Giulia; Maccari, Chiara; Vanderwert, Fiorenza; Mannelli, Francesco; Della Porta, Matteo; Manfredini, Rossella; Vannucchi, Alessandro Maria; Guglielmelli, Paola
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature
2020 Coltro, Giacomo; Mannelli, Francesco; Vergoni, Federica; Santi, Raffaella; Massi, Daniela; Siliani, Luisa Margherita; Marzullo, Antonella; Bonifacio, Stefania; Pelo, Elisabetta; Pacilli, Annalisa; Paoli, Chiara; Franci, Annalisa; Calabresi, Laura; Bosi, Alberto; Vannucchi, Alessandro Maria; Guglielmelli, Paola
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells
2022 Calabresi, Laura; Balliu, Manjola; Bartalucci, Niccolò
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model
2023 Bianchi, Elisa; Rontauroli, Sebastiano; Tavernari, Lara; Mirabile, Margherita; Pedrazzi, Francesca; Genovese, Elena; Sartini, Stefano; Dall'Ora, Massimiliano; Grisendi, Giulia; Fabbiani, Luca; Maccaferri, Monica; Carretta, Chiara; Parenti, Sandra; Fantini, Sebastian; Bartalucci, Niccolò; Calabresi, Laura; Balliu, Manjola; Guglielmelli, Paola; Potenza, Leonardo; Tagliafico, Enrico; Losi, Lorena; Dominici, Massimo; Luppi, Mario; Vannucchi, Alessandro Maria; Manfredini, Rossella
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis
2017 Bartalucci, Niccolã²; Calabresi, Laura; Balliu, Manjola; Martinelli, Serena; Rossi, Maria Caterina; Villeval, Jean Luc; Annunziato, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro M.
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis
2022 Guglielmelli P, Irushani Vanderwert F, Romagnoli S, Coltro G, Loscocco GG, Mannelli F, Calabresi L, Gentili G, Rotunno G, Bartalucci N, Boldrini V, Sant'Antonio E, Tarantino D, Pieraccioli M, Vannucchi AM
The MPL mutation
2021 Guglielmelli, Paola; Calabresi, Laura
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
2015 Guglielmelli, P; Rotunno, G; Fanelli, T; Pacilli, A; Brogi, G; Calabresi, L; Pancrazzi, A; Vannucchi, A M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs | 2021 | Balliu M.; Calabresi L.; Bartalucci N.; Romagnoli S.; Maggi L.; Manfredini R.; Lulli M.; Guglielmelli P.; Vannucchi A.M. | |
| CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles | 2017 | Zini, Roberta; Guglielmelli, Paola; Pietra, Daniela; Rumi, Elisa; Rossi, Chiara; Rontauroli, Sebastiano; Genovese, Elena; Fanelli, Tiziana; Calabresi, Laura; Bianchi, Elisa; Salati, Simona; Cazzola, Mario; Tagliafico, Enrico; Vannucchi, Alessandro M.; Manfredini, Rossella | |
| Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants | 2019 | Salati S.; Genovese E.; Carretta C.; Zini R.; Bartalucci N.; Prudente Z.; Pennucci V.; Ruberti S.; Rossi C.; Rontauroli S.; Enzo E.; Calabresi L.; Balliu M.; Mannarelli C.; Bianchi E.; Guglielmelli P.; Tagliafico E.; Vannucchi A.M.; Manfredini R. | |
| Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value | 2014 | Vannucchi, A.M.; Rotunno, G.; Bartalucci, N.; Raugei, G.; Carrai, V.; Balliu, M.; Mannarelli, C.; Pacilli, A.; Calabresi, L.; Fjerza, R.; Pieri, L.; Bosi, A.; Manfredini, R.; Guglielmelli, P. | |
| Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. | 2014 | Vannucchi AM;Rotunno G;Bartalucci N;Raugei G;Carrai V;Balliu M;Mannarelli C;Pacilli A;Calabresi L;Fjerza R;Pieri L;Bosi A;Manfredini R;Guglielmelli P | |
| Characterization of novel molecular targets and mechanisms in Philadelphia-negative Myeloproliferative Neoplasms | 2018 | CALABRESI LAURA | |
| Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms | 2023 | Calabresi, Laura; Carretta, Chiara; Romagnoli, Simone; Rotunno, Giada; Parenti, Sandra; Bertesi, Matteo; Bartalucci, Niccolò; Rontauroli, Sebastiano; Chiereghin, Chiara; Castellano, Sara; Gentili, Giulia; Maccari, Chiara; Vanderwert, Fiorenza; Mannelli, Francesco; Della Porta, Matteo; Manfredini, Rossella; Vannucchi, Alessandro Maria; Guglielmelli, Paola | |
| Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms | 2023 | Calabresi, Laura; Carretta, Chiara; Romagnoli, Simone; Rotunno, Giada; Parenti, Sandra; Bertesi, Matteo; Bartalucci, Niccolò; Rontauroli, Sebastiano; Chiereghin, Chiara; Castellano, Sara; Gentili, Giulia; Maccari, Chiara; Vanderwert, Fiorenza; Mannelli, Francesco; Della Porta, Matteo; Manfredini, Rossella; Vannucchi, Alessandro Maria; Guglielmelli, Paola | |
| Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature | 2020 | Coltro, Giacomo; Mannelli, Francesco; Vergoni, Federica; Santi, Raffaella; Massi, Daniela; Siliani, Luisa Margherita; Marzullo, Antonella; Bonifacio, Stefania; Pelo, Elisabetta; Pacilli, Annalisa; Paoli, Chiara; Franci, Annalisa; Calabresi, Laura; Bosi, Alberto; Vannucchi, Alessandro Maria; Guglielmelli, Paola | |
| Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells | 2022 | Calabresi, Laura; Balliu, Manjola; Bartalucci, Niccolò | |
| Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model | 2023 | Bianchi, Elisa; Rontauroli, Sebastiano; Tavernari, Lara; Mirabile, Margherita; Pedrazzi, Francesca; Genovese, Elena; Sartini, Stefano; Dall'Ora, Massimiliano; Grisendi, Giulia; Fabbiani, Luca; Maccaferri, Monica; Carretta, Chiara; Parenti, Sandra; Fantini, Sebastian; Bartalucci, Niccolò; Calabresi, Laura; Balliu, Manjola; Guglielmelli, Paola; Potenza, Leonardo; Tagliafico, Enrico; Losi, Lorena; Dominici, Massimo; Luppi, Mario; Vannucchi, Alessandro Maria; Manfredini, Rossella | |
| Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis | 2017 | Bartalucci, Niccolã²; Calabresi, Laura; Balliu, Manjola; Martinelli, Serena; Rossi, Maria Caterina; Villeval, Jean Luc; Annunziato, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro M. | |
| Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis | 2022 | Guglielmelli P, Irushani Vanderwert F, Romagnoli S, Coltro G, Loscocco GG, Mannelli F, Calabresi L, Gentili G, Rotunno G, Bartalucci N, Boldrini V, Sant'Antonio E, Tarantino D, Pieraccioli M, Vannucchi AM | |
| The MPL mutation | 2021 | Guglielmelli, Paola; Calabresi, Laura | |
| Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis | 2015 | Guglielmelli, P; Rotunno, G; Fanelli, T; Pacilli, A; Brogi, G; Calabresi, L; Pancrazzi, A; Vannucchi, A M |